Bioequivalence Study of Ibuprofen 200 mg/5 mL Oral Suspension vs. MOMENT 200 mg Coated Tablet
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The main objective of the study is to evaluate the bioequivalence of a new formulation of
ibuprofen 200 mg/5 mL oral suspension vs. the marketed reference product MOMENT 200 mg coated
tablet, when administered under fasting conditions as single oral dose to healthy male and
female volunteers, in two consecutive study periods.